4.7 Article

Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

Journal

CHEMICAL COMMUNICATIONS
Volume 47, Issue 32, Pages 9176-9178

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c1cc12961a

Keywords

-

Funding

  1. Ministry of Health & Welfare, Republic of Korea [A080855]
  2. Korean government (MEST) [2011-0017377, 2010-0027955]

Ask authors/readers for more resources

A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T(1)-weighted in vivo MRI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available